These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 25844311)

  • 1. Multimodal MRI and cognitive function in patients with breast cancer prior to adjuvant treatment--the role of fatigue.
    Menning S; de Ruiter MB; Veltman DJ; Koppelmans V; Kirschbaum C; Boogerd W; Reneman L; Schagen SB
    Neuroimage Clin; 2015; 7():547-54. PubMed ID: 25844311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study.
    Schilder CM; Eggens PC; Seynaeve C; Linn SC; Boogerd W; Gundy CM; Beex LV; Van Dam FS; Schagen SB
    Acta Oncol; 2009; 48(1):76-85. PubMed ID: 18777410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
    Castellon SA; Ganz PA; Bower JE; Petersen L; Abraham L; Greendale GA
    J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
    Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
    Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment worry and neurocognitive responses in women with breast cancer.
    Berman MG; Askren MK; Jung M; Therrien B; Peltier S; Noll DC; Zhang M; Ossher L; Hayes DF; Reuter-Lorenz PA; Cimprich B
    Health Psychol; 2014 Mar; 33(3):222-31. PubMed ID: 23914817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study.
    Schilder CM; Seynaeve C; Linn SC; Boogerd W; Beex LV; Gundy CM; Nortier JW; van de Velde CJ; van Dam FS; Schagen SB
    Psychooncology; 2012 May; 21(5):479-87. PubMed ID: 21351188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chemotherapy and psychosocial distress on perceived cognitive disturbances in Asian breast cancer patients.
    Cheung YT; Shwe M; Chui WK; Chay WY; Ang SF; Dent RA; Yap YS; Lo SK; Ng RC; Chan A
    Ann Pharmacother; 2012 Dec; 46(12):1645-55. PubMed ID: 23249868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer.
    Tchen N; Juffs HG; Downie FP; Yi QL; Hu H; Chemerynsky I; Clemons M; Crump M; Goss PE; Warr D; Tweedale ME; Tannock IF
    J Clin Oncol; 2003 Nov; 21(22):4175-83. PubMed ID: 14615445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining the effects of adjuvant chemotherapy on cognition and the impact of any cognitive impairment on quality of life in colorectal cancer patients: study protocol.
    Dwek MR; Rixon L; Simon A; Hurt C; Newman S
    BMC Psychol; 2015 Nov; 3():43. PubMed ID: 26612628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study.
    Fan HG; Houédé-Tchen N; Yi QL; Chemerynsky I; Downie FP; Sabate K; Tannock IF
    J Clin Oncol; 2005 Nov; 23(31):8025-32. PubMed ID: 16258100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year longitudinal study of fatigue, cognitive functions, and quality of life after adjuvant radiotherapy for breast cancer.
    Noal S; Levy C; Hardouin A; Rieux C; Heutte N; Ségura C; Collet F; Allouache D; Switsers O; Delcambre C; Delozier T; Henry-Amar M; Joly F
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):795-803. PubMed ID: 20888704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in brain activation in breast cancer patients depend on cognitive domain and treatment type.
    Menning S; de Ruiter MB; Veltman DJ; Boogerd W; Oldenburg HS; Reneman L; Schagen SB
    PLoS One; 2017; 12(3):e0171724. PubMed ID: 28267750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment.
    Downie FP; Mar Fan HG; Houédé-Tchen N; Yi Q; Tannock IF
    Psychooncology; 2006 Oct; 15(10):921-30. PubMed ID: 16477674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very Late Treatment-Related Alterations in Brain Function of Breast Cancer Survivors.
    Stouten-Kemperman MM; de Ruiter MB; Boogerd W; Veltman DJ; Reneman L; Schagen SB
    J Int Neuropsychol Soc; 2015 Jan; 21(1):50-61. PubMed ID: 25529014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivors.
    Breckenridge LM; Bruns GL; Todd BL; Feuerstein M
    Psychooncology; 2012 Jan; 21(1):43-53. PubMed ID: 20967847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromarkers of fatigue and cognitive complaints following chemotherapy for breast cancer: a prospective fMRI investigation.
    Askren MK; Jung M; Berman MG; Zhang M; Therrien B; Peltier S; Ossher L; Hayes DF; Reuter-Lorenz PA; Cimprich B
    Breast Cancer Res Treat; 2014 Sep; 147(2):445-55. PubMed ID: 25138546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy.
    Ferguson RJ; McDonald BC; Saykin AJ; Ahles TA
    J Clin Oncol; 2007 Sep; 25(25):3866-70. PubMed ID: 17761972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors.
    Schilder CM; Seynaeve C; Linn SC; Boogerd W; Beex LV; Gundy CM; Nortier JW; van de Velde CJ; van Dam FS; Schagen SB
    Crit Rev Oncol Hematol; 2010 Nov; 76(2):133-41. PubMed ID: 20036141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mechanistic cohort study evaluating cognitive impairment in women treated for breast cancer.
    Vardy JL; Stouten-Kemperman MM; Pond G; Booth CM; Rourke SB; Dhillon HM; Dodd A; Crawley A; Tannock IF
    Brain Imaging Behav; 2019 Feb; 13(1):15-26. PubMed ID: 28466438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.